A detailed history of Primecap Management CO transactions in Pulmonx Corp stock. As of the latest transaction made, Primecap Management CO holds 5,739,427 shares of LUNG stock, worth $36.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,739,427
Previous 5,646,451 1.65%
Holding current value
$36.7 Million
Previous $72 Million 26.1%
% of portfolio
0.04%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$8.71 - $14.65 $809,820 - $1.36 Million
92,976 Added 1.65%
5,739,427 $53.2 Million
Q4 2023

Feb 09, 2024

BUY
$7.89 - $13.14 $978,754 - $1.63 Million
124,050 Added 2.25%
5,646,451 $72 Million
Q3 2023

Nov 13, 2023

BUY
$9.88 - $14.0 $26,478 - $37,520
2,680 Added 0.05%
5,522,401 $57 Million
Q2 2023

Aug 11, 2023

BUY
$10.78 - $13.65 $183,260 - $232,050
17,000 Added 0.31%
5,519,721 $72.4 Million
Q4 2022

Feb 13, 2023

BUY
$4.92 - $17.35 $344,252 - $1.21 Million
69,970 Added 1.29%
5,502,721 $46.4 Million
Q3 2022

Nov 14, 2022

BUY
$15.35 - $23.99 $539,245 - $842,768
35,130 Added 0.65%
5,432,751 $90.5 Million
Q2 2022

Aug 11, 2022

SELL
$14.0 - $27.95 $677,180 - $1.35 Million
-48,370 Reduced 0.89%
5,397,621 $79.5 Million
Q1 2022

May 11, 2022

BUY
$21.13 - $35.65 $10.6 Million - $17.9 Million
502,100 Added 10.16%
5,445,991 $135 Million
Q4 2021

Feb 11, 2022

BUY
$29.72 - $45.1 $58.6 Million - $88.9 Million
1,970,200 Added 66.25%
4,943,891 $159 Million
Q3 2021

Nov 12, 2021

BUY
$35.98 - $44.48 $36.5 Million - $45.1 Million
1,014,348 Added 51.77%
2,973,691 $107 Million
Q2 2021

Aug 10, 2021

BUY
$37.61 - $48.0 $28.9 Million - $36.8 Million
767,343 Added 64.37%
1,959,343 $86.4 Million
Q1 2021

May 14, 2021

BUY
$44.0 - $67.54 $20.2 Million - $31 Million
459,500 Added 62.73%
1,192,000 $54.5 Million
Q4 2020

Feb 08, 2021

BUY
$39.31 - $69.02 $28.8 Million - $50.6 Million
732,500 New
732,500 $50.6 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $238M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.